Operation of a smoking harm laboratory

Basis for Establishment

Articles 9 and 10 of the WHO [World Health Organization] FCTC [Framework Convention on Tobacco Control]

The Conference of the Parties, in consultation with competent international bodies, shall propose guidelines for testing and measuring the content and emissions of tobacco products, and for regulating them. Each Party shall, where approved by its competent national authorities, adopt and implement effective legislative, executive, administrative or other measures for such testing, measuring, and regulation.

Smoking Damage Prevention TF [Task Force] By December '16), Division of Respiratory and Allergic Diseases (January '17 – September '20), Korea Centers for Disease Control and Prevention.
Division of Health Hazard Response, Bureau of Health Hazard Response (September '20 – May '24), Korea Disease Control and Prevention Agency.
Division of Climate Health and Health Hazard Preparedness, Bureau of Health Hazard Response (May '24 – Present), Korea Disease Control and Prevention Agency.

To secure the capability for analyzing the components of tobacco product emissions and for testing clinical biomarkers at the level of an internationally accredited testing laboratory (ISO 17025)
To conduct research to establish evidence related to the human health risks of tobacco, such as biomarkers for monitoring the level of direct and indirect smoking exposure at the national level
To participate in collaborative research for the development of standard operating procedures for tobacco component analysis as a member of the WHO Tobacco Laboratory Network (TobLabnet)